GlassScriptPhysician profile
Petra Mcewan
NPI 1538302021
$1,627.58
in general payments reported to CMS, 2019-2025
24 companies · $19.52 in 2025
The $19.52 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $91.83 · 2021: $306 · 2022: $357 · 2023: $255 · 2024: $375 · 2025: $19.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $313.60 | 2020-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $204.72 | 2021-2024 | |
| Pfizer INC. | $136.71 | 2019-2024 | |
| Phadia US INC. | $136.15 | 2019-2023 | Immunocap |
| Ultragenyx Pharmaceutical INC. | $77.40 | 2021-2024 | Crysvita |
| Glaxosmithkline, LLC. | $62.43 | 2023-2024 | Bexsero |
| Stryker Corporation | $61.62 | 2023 | Easyfuse |
| Kaleo, INC. | $61.10 | 2019-2024 | Auvi-Q |
| Verrica Pharmaceuticals INC. | $59.75 | 2023-2024 | Ycanth |
| Cranial Technologies, INC | $58.56 | 2021-2023 | Doc Band |
| Merck Sharp & Dohme LLC | $57.53 | 2019-2024 | Gardasil 9, Gardasil, Vaxelis |
| Ironshore Pharmaceuticals INC. | $56.24 | 2019-2023 | Jornay Pm |
| Corium, LLC | $54.99 | 2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $53.81 | 2021-2022 | |
| Abbvie INC. | $47.68 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $38.01 | 2021 | |
| Seqirus USA INC | $23.62 | 2024 | Flucelvax |
| Aimmune Therapeutics, INC. | $21.26 | 2023 | |
| Sanofi-Aventis U.S. LLC | $20.71 | 2024 | |
| Exact Sciences Corporation | $19.52 | 2025 | The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $18.10 | 2024 | Flumist Quadrivalent |
| Shire North American Group INC | $16.54 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.15 | 2019 | |
| Acacia Pharma INC | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petra Mcewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.